Cannabis Against Raynauds Scleroderma

There is limited research on the use of medical cannabis for Raynaud's scleroderma, a condition characterized by the narrowing of blood vessels in response to cold or stress, leading to reduced blood flow to the fingers and toes. However, some studies suggest that cannabis may have vasodilatory properties, meaning that it can widen blood vessels and improve blood flow.

Additionally, cannabinoids found in cannabis, such as THC and CBD, can interact with the body's endocannabinoid system, which plays a role in regulating pain perception, inflammation, and immune function. This interaction can help reduce pain and inflammation associated with scleroderma.

What Studies Exist to Support the Use of Cannabis Against Raynauds Scleroderma?

There is limited research on the use of medical cannabis for Raynaud's scleroderma, and the studies that do exist are mostly small and preliminary. Here are a few studies that have looked at the potential use of medical cannabis for Raynaud's scleroderma:

In a 2018 case report published in the Journal of Medical Case Reports, a 45-year-old woman with Raynaud's syndrome and systemic sclerosis found that smoking cannabis improved her symptoms, including reducing the frequency and duration of her attacks.

A 2019 study published in the Journal of Scleroderma and Related Disorders examined the experiences of 33 patients with systemic sclerosis who reported using cannabis for various symptoms, including Raynaud's phenomenon. The study found that most patients reported subjective improvements in pain, sleep, and quality of life, although the sample size was small and the study did not use objective measures to evaluate changes in symptoms.

Another 2019 case report published in the Journal of Pain and Symptom Management described a 77-year-old man with systemic sclerosis who found that topical application of a cannabis-based cream reduced the severity and frequency of his Raynaud attacks.

Does Cannabis for Raynauds Scleroderma have side effects?

The side effects of using medical cannabis for pain, palliative, and cancer care can vary depending on the individual, the method of use, the dosage, and the type of cannabis used. 

It can range from Psychotropic effects like euphoria, drowsiness, dizziness, and confusion to cognitive ones including issues related to memory, attention, and reaction time. Besides, smoking or inhaling cannabis can cause respiratory irritation, coughing, and bronchitis. This can be a concern for patients with preexisting lung conditions.

Cannabis can also cause changes in heart rate and blood pressure, which can be problematic for patients with cardiovascular disease and gastrointestinal discomfort, including nausea, vomiting, and diarrhea.

Key takeaways

• Limited research has been conducted on the use of medical cannabis for Raynaud's scleroderma.

• Cannabis may have vasodilatory properties and can widen blood vessels, potentially improving blood flow in people with Raynaud's scleroderma.

• Cannabinoids found in cannabis can interact with the body's endocannabinoid system, which can help reduce pain and inflammation associated with scleroderma.

Please note: It's important to note that the use of medical cannabis for Raynaud's scleroderma should only be considered under the guidance of a healthcare professional, as there may be potential risks and side effects associated with its use.